Skip to main content
Top
Published in: Diabetologia 6/2008

01-06-2008 | Article

Primarily non-surgical management of osteomyelitis of the foot in diabetes

Authors: F. L. Game, W. J. Jeffcoate

Published in: Diabetologia | Issue 6/2008

Login to get access

Abstract

Aims/hypothesis

We examined the use of surgery and assessed the response to non-surgical management of osteomyelitis of the foot in diabetic patients.

Methods

We reviewed the records of all patients presenting to a single specialist centre with osteomyelitis complicating a diabetic foot ulcer over a 5 year period. Details were extracted on antibiotic choice and treatment duration, hospital admission, incidence of minor and major amputation, and 12 month outcomes.

Results

There were 147 patients, with mean age 64.7 years (66% men). Of these, 26 (18%) were admitted to hospital at the time of presentation and managed with intravenous antibiotics; the remainder were managed with oral antibiotics as outpatients. Surgery was undertaken because of life- or limb-threatening infection, or failure to respond, in 34 (23%) patients (minor amputation 28, major amputation six patients). The remaining 113 were managed non-surgically. Remission was induced in 66 (58.4% of 113), while 35 (31%) had a relapse. Of those experiencing relapse, 27 (77%) achieved apparent arrest of the infection with a further course of antibiotics; six underwent minor and two underwent major amputation. Of all 113 whose infection was initially managed without surgery, apparent remission was achieved with antibiotics alone in 93 (82.3%).

Conclusions/interpretation

As these observations were made in an unselected case series, they give more insight into the respective roles of surgical and non-surgical management. The results confirm that although urgent surgery is indicated in some patients, non-surgical management of those without limb-threatening infection is associated with a high rate of apparent remission.
Literature
1.
go back to reference Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA (2006) Risk factors for foot infections in individuals with diabetes. Diabetes Care 29:1288–1293PubMedCrossRef Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA (2006) Risk factors for foot infections in individuals with diabetes. Diabetes Care 29:1288–1293PubMedCrossRef
2.
go back to reference Lipsky BA (2004) A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 20(Suppl 1): S68–S77PubMedCrossRef Lipsky BA (2004) A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 20(Suppl 1): S68–S77PubMedCrossRef
3.
go back to reference Lipsky BA, Berendt AR, Deery HG 2nd et al (2004) IDSA Guidelines: diagnosis and treatment of diabetic foot infections. Clin Inf Dis 39:885–910CrossRef Lipsky BA, Berendt AR, Deery HG 2nd et al (2004) IDSA Guidelines: diagnosis and treatment of diabetic foot infections. Clin Inf Dis 39:885–910CrossRef
4.
go back to reference Berendt RA, Peters EJG, Bakker K et al (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. DOI 10.1002/dmrr.836 Berendt RA, Peters EJG, Bakker K et al (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. DOI 10.​1002/​dmrr.​836
5.
go back to reference Henke PK, Blackburn SA, Wain RW et al (2005) Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg 241:885–894PubMedCrossRef Henke PK, Blackburn SA, Wain RW et al (2005) Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg 241:885–894PubMedCrossRef
6.
go back to reference Jeffcoate WJ, Lipsky BA (2004) Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 39(Suppl 2):S115–S122PubMedCrossRef Jeffcoate WJ, Lipsky BA (2004) Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 39(Suppl 2):S115–S122PubMedCrossRef
7.
go back to reference Embil JM, Rose G, Trepman E et al (2006) Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 27:771–779PubMed Embil JM, Rose G, Trepman E et al (2006) Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 27:771–779PubMed
8.
go back to reference Treece KA, Macfarlane RM, Pound N, Game FL, Jeffcoate WJ (2004) Validation of a system of foot ulcer classification in diabetes mellitus. Diabet Med 21:987–991PubMedCrossRef Treece KA, Macfarlane RM, Pound N, Game FL, Jeffcoate WJ (2004) Validation of a system of foot ulcer classification in diabetes mellitus. Diabet Med 21:987–991PubMedCrossRef
10.
go back to reference Bamberger DM, Daus GP, Gerding DN (1987) Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 83:653–660PubMedCrossRef Bamberger DM, Daus GP, Gerding DN (1987) Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 83:653–660PubMedCrossRef
11.
go back to reference Nix DE, Cumbo TJ, Kuritsky P, Devito JM, Schentag JJ (1987) Oral ciprofloxacin in the treatment of serious soft tissue infection: efficacy, safety and pharmacokinetics. Am J Med 82(Suppl):146–215PubMed Nix DE, Cumbo TJ, Kuritsky P, Devito JM, Schentag JJ (1987) Oral ciprofloxacin in the treatment of serious soft tissue infection: efficacy, safety and pharmacokinetics. Am J Med 82(Suppl):146–215PubMed
12.
go back to reference Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding DN (1989) Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus. Am J Med 86:801–807PubMedCrossRef Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding DN (1989) Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus. Am J Med 86:801–807PubMedCrossRef
13.
go back to reference Ha Van G, Siney H, Danan JP, Sachon C, Grimaldi A (1996) Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diabetes Care 19:1257–1260PubMedCrossRef Ha Van G, Siney H, Danan JP, Sachon C, Grimaldi A (1996) Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diabetes Care 19:1257–1260PubMedCrossRef
14.
go back to reference Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate WJ (1997) Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 14:487–490PubMedCrossRef Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate WJ (1997) Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 14:487–490PubMedCrossRef
15.
go back to reference Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD (1999) Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 159:851–856PubMedCrossRef Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD (1999) Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 159:851–856PubMedCrossRef
16.
go back to reference Eneroth M, Larsson J, Apelqvist J (1999) Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications 13:254–263CrossRef Eneroth M, Larsson J, Apelqvist J (1999) Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications 13:254–263CrossRef
17.
go back to reference Senneville E, Yazdanpanah Y (2001) Cazaubiel M et al Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 48:927–930PubMedCrossRef Senneville E, Yazdanpanah Y (2001) Cazaubiel M et al Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 48:927–930PubMedCrossRef
18.
go back to reference Yadlapalli N, Vaishnar A, Sheehan P (2002) Conservative management of diabetic foot ulcers complicated by osteomyelitis. Wounds 14:31–35 Yadlapalli N, Vaishnar A, Sheehan P (2002) Conservative management of diabetic foot ulcers complicated by osteomyelitis. Wounds 14:31–35
19.
go back to reference Game FL, Jeffcoate WJ (2006) MRSA isolation from diabetic foot ulcers—does it affect healing and is the problem getting worse? (Abstract) Diabetes 55(Suppl 1):99–OR Game FL, Jeffcoate WJ (2006) MRSA isolation from diabetic foot ulcers—does it affect healing and is the problem getting worse? (Abstract) Diabetes 55(Suppl 1):99–OR
Metadata
Title
Primarily non-surgical management of osteomyelitis of the foot in diabetes
Authors
F. L. Game
W. J. Jeffcoate
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0976-1

Other articles of this Issue 6/2008

Diabetologia 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.